Tag Archives: SIFY

Technology Sector Marks Solo Flight to Red Territory; Microsoft (MSFT) May Have Sold Out Initial Run of $499 version of Surface while Fortinet (FTNT) Plunges to Record Low – MSFT, FTNT, YHOO, CYMI, SIFY, CHKP

Posted on October 18, 2012 by Thomas Vedder

Earlier day trading session data showed that Technology sector reacted negatively and only sector finished lower on Wednesday. Cymer, Inc (NASDAQ:CYMI) and Sify Technologies Limited (ADR) (NASDAQ:SIFY) were major percentage gainer in this sector while major decliner was Check Point …

Posted in Latest Headlines, Technology | Tagged Check Point Software, CHKP, Cymer, CYMI, Fortinet, FTNT, Microsoft, MSFT, NASDAQ:CHKP, NASDAQ:CYMI, NASDAQ:FTNT, NASDAQ:MSFT, NASDAQ:SIFY, NASDAQ:YHOO, SIFY, Sify Technologies, Yahoo, YHOO | Comments Off

Big time losers and the reasons why (SIFY, BGC, ASIA)

Posted on November 1, 2011 by Josie Middleton

In this report: Sify Technologies (NASDAQ:SIFY), General Cable Corp. (NYSE:BGC) and AsiaInfo-Linkage (NASDAQ:ASIA).

Sify Technologies (NASDAQ:SIFY) has dropped more than 22 percent today after skyrocketing by more than 60 percent on Monday following the companies latest quarterly report. The company …

Posted in Latest Headlines, Reports | Tagged Analysts, Asia, AsiaInfo-Linkage, BGC, company, demand, estimates, expected, General Cable Corp., income, NASDAQ, NASDAQ:ASIA, NASDAQ:SIFY, net income, NYSE, NYSE:BGC, prices, quarterly, released, report, results, revenue, SIFY, Sify Technologies, trades, value, Wall Street | Comments Off

Whats up Momenta Pharmaceuticals, Sify Technology and The Shaw Group?

Posted on October 31, 2011 by Josie Middleton

In this report: Momenta Pharmaceuticals (NASDAQ:MNTA), Sify Technologies Limited (NASDAQ:SIFY) and The Shaw Group (NASDAQ:SHAW).

Momenta Pharmaceuticals (NASDAQ:MNTA) is trading over 20 percent higher today after the company announced that a court ruled in favor of keeping its competition for …

Posted in Latest Headlines, Reports | Tagged CEO, chemical, company, competition, corporate, court, Energy, enoxaparin, expenses, growth, infringed, loss, market, MNTA, Momenta Pharmaceuticals, NASDAQ, NASDAQ:MNTA, NASDAQ:SHAW, NASDAQ:SIFY, net loss, patents, quarter, released, results, revenue, sell, SHAW, SIFY, Sify Technologies Limited, The Shaw Group, trading, unit, Wall Street | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

Tag Archives: SIFY

Technology Sector Marks Solo Flight to Red Territory; Microsoft (MSFT) May Have Sold Out Initial Run of $499 version of Surface while Fortinet (FTNT) Plunges to Record Low – MSFT, FTNT, YHOO, CYMI, SIFY, CHKP

Big time losers and the reasons why (SIFY, BGC, ASIA)

Whats up Momenta Pharmaceuticals, Sify Technology and The Shaw Group?

Follow us

Most Popular Posts

blogs